Quinolonecarboxylic acid derivatives and their use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514312, 540575, 544324, 544349, 544350, 544363, 546113, 546114, 546156, C07D41704, C07D41706, A61K 31495

Patent

active

055190243

ABSTRACT:
A composition comprises a 1,7-disubstituted-4-oxo-3-quinolinecarboxylic acid or 1,7-disubstituted-4-oxo-3-naphthyridinecarboxylic acid derivative which is useful as a prophylactic and/or therapeutic agent for peripheral arterial obstruction, acute myocardial infarction, an antitumor agent, and as a prophylactic and/or therapeutic agent for osteoporosis.

REFERENCES:
patent: 5039805 (1991-08-01), Alig et al.
patent: 5258510 (1993-11-01), Ogawa et al.
Patent Abstracts of Japan, vol. 11, No. 101, Mar. 31, 1987 (C-413) corresponding to JP-A-61 251 667 (Nov. 6, 1986)
Patent Abstracts of Japan, vol. 14, No. 443, Sep. 21, 1990 (C-0762) corresponding to JP-A-02 174 797 (Jul. 6, 1990).
Domagala et. al., J. Med Chem. 31, pp. 991-1001 (1988).
Izzo et. al., J. Heterocyclic Chem. 25, pp. 289-295 (1988).
Chemical Abstracts, 114:206981 (1990).
Chemical Abstracts, 112:210528 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Quinolonecarboxylic acid derivatives and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinolonecarboxylic acid derivatives and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolonecarboxylic acid derivatives and their use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2038270

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.